B
Brighter Biotechnology (Shanghai)
A company committed to providing professional and compliant biosafety testing, methodology development, target verification evaluation and related detection kit products
About Brighter Biotechnology (Shanghai)
Brighter Biotechnology (Shanghai) Co., Ltd., also known as BRC Biotechnology, was established in 2022 and has positioned itself as a specialized service provider within China's life sciences sector. The company operates from a substantial 6,000-square-meter facility located in the Simbay Park of the Shanghai Free Trade Pilot Zone. This modern platform is engineered to meet both cGMP (current Good Manufacturing Practice) and Biosafety Level 2 (BSL-2) standards, enabling it to handle a range of sensitive biological materials.
The firm's core business revolves around offering critical support services to the biopharmaceutical industry. Its service portfolio includes compliant biosafety testing, the development of sophisticated analytical methodologies, and target validation evaluations. Brighter Biotechnology also develops and supplies related detection kit products. The business model is focused on providing these outsourced services, acting as a technical partner to its clients.
Brighter Biotechnology serves a client base engaged in advanced therapeutic modalities. The company specifically caters to developers of cell and gene therapies, monoclonal antibodies, vaccines, and nucleic acid-based drugs. By offering these specialized testing and development services locally, the company aims to provide the Chinese biopharmaceutical market with internationally benchmarked support, reducing the need for companies to seek such services abroad.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Jul 2023 | $14M | $55M | Legend Capital | ↗ |
Growth signals
Latest recorded traffic for Brighter Biotechnology (Shanghai) is 1.2K monthly website visits, up 0% over the last three months. Brighter Biotechnology (Shanghai)'s team declined 9.1% over the past year.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Brighter Biotechnology (Shanghai) in its local ecosystem
The Brighter Biotechnology (Shanghai) office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Brighter Biotechnology (Shanghai) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Brighter Biotechnology (Shanghai)’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.
